|
NZ580327A
(en)
*
|
2007-04-03 |
2012-02-24 |
Array Biopharma Inc |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
|
|
ES2386851T3
(es)
|
2007-11-30 |
2012-09-03 |
Novartis Ag |
Alquil (C2-C5)-imidazol-bisfosfonatos
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
*
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
ES2635504T3
(es)
|
2009-01-21 |
2017-10-04 |
Rigel Pharmaceuticals, Inc. |
Derivados de N2-(3-piridilo o fenil)-N4-(4-piperidil)-2,4-pirimidinadiamina útiles en el tratamiento de enfermedades inflamatorias, toimmunitarias o proliferativas
|
|
KR20120061063A
(ko)
|
2009-06-05 |
2012-06-12 |
화이자 인코포레이티드 |
Ｇｐｒ 119 조절제로서의 ｌ-(피페리딘-4-일)-피라졸 유도체
|
|
CA2778949C
(en)
|
2009-10-30 |
2018-02-27 |
Janssen Pharmaceutica Nv |
Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
|
|
EP2332917B1
(en)
*
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
|
FR2952934B1
(fr)
*
|
2009-11-23 |
2012-06-22 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
CA2814826C
(en)
|
2010-11-17 |
2019-02-12 |
Actelion Pharmaceuticals Ltd |
Bridged spiro[2.4]heptane ester derivatives
|
|
UA111075C2
(uk)
|
2011-02-25 |
2016-03-25 |
Еррей Біофарма Інк. |
Триазолопіридинові сполуки як інгібітори кінази рім
|
|
EP2524915A1
(en)
|
2011-05-20 |
2012-11-21 |
Sanofi |
2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
|
|
BR112013033375B1
(pt)
|
2011-06-27 |
2022-05-10 |
Janssen Pharmaceutica N.V |
Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013007768A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
|
|
MY167575A
(en)
|
2011-10-14 |
2018-09-20 |
Ambit Biosciences Corp |
Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
|
|
MA37618B1
(fr)
|
2012-05-16 |
2017-08-31 |
Actelion Pharmaceuticals Ltd |
Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx
|
|
RU2657540C2
(ru)
|
2012-06-26 |
2018-06-14 |
Янссен Фармацевтика Нв |
Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств
|
|
EP2869822B1
(en)
|
2012-07-09 |
2016-09-14 |
Janssen Pharmaceutica, N.V. |
Inhibitors of phosphodiesterase 10 enzyme
|
|
EP2900238B1
(en)
|
2012-09-28 |
2017-12-06 |
Vanderbilt University |
Fused heterocyclic compounds as selective bmp inhibitors
|
|
EP2943485B1
(en)
|
2013-01-14 |
2017-09-20 |
Incyte Holdings Corporation |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
|
|
ME03780B
(me)
|
2013-01-15 |
2021-04-20 |
Incyte Holdings Corp |
Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze
|
|
TW201605866A
(zh)
|
2013-08-23 |
2016-02-16 |
英塞特公司 |
可用作ｐｉｍ激酶抑制劑之呋喃并－及噻吩并－吡啶甲醯胺化合物
|
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
CN104597194B
(zh)
*
|
2015-01-15 |
2016-07-06 |
武汉轻工大学 |
3-氯-1，2-丙二醇的高效液相色谱-荧光检测方法
|
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
SG11202002032SA
(en)
|
2017-09-22 |
2020-04-29 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
|
CA3076476A1
(en)
|
2017-10-18 |
2019-04-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as pad inhibitors
|
|
BR112020008851A2
(pt)
|
2017-11-06 |
2020-10-20 |
Jubilant Prodel LLC |
composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
|
|
PL3704120T3
(pl)
|
2017-11-24 |
2024-09-16 |
Jubilant Episcribe Llc |
Związki heterocykliczne jako inhibitory prmt5
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
SG11202008950PA
(en)
|
2018-03-13 |
2020-10-29 |
Jubilant Prodel LLC |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
US10745400B2
(en)
|
2018-03-14 |
2020-08-18 |
Vanderbuilt University |
Inhibition of BMP signaling, compounds, compositions and uses thereof
|
|
CN110833556A
(zh)
*
|
2018-08-15 |
2020-02-25 |
广西梧州制药（集团）股份有限公司 |
吡唑并嘧啶衍生物在治疗肝纤维化的用途
|
|
BR112023001952A2
(pt)
*
|
2020-08-05 |
2023-02-28 |
Massachusetts Gen Hospital |
Inibidores de quinase induzíveis por sal
|